Acipimox (Standard)
Product Specifications
UNSPSC Description
Acipimox (Standard) is the analytical standard of Acipimox. This product is intended for research and analytical applications. Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity[1][2][3].
Target Antigen
Others
Type
Reference Standards
Related Pathways
Others
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/acipimox-standard.html
Smiles
O=C(C1=C[N+]([O-])=C(C)C=N1)O
Molecular Weight
154.12
References & Citations
[1]Vestergaard ET, et, al. Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation. Br J Clin Pharmacol. 2017 Dec;83(12):2671-2677.|[2]Wang-Fisher YL, et, al. Acipimox stimulates leptin production from isolated rat adipocytes. J Endocrinol. 2002 Aug;174(2):267-72.|[3]Ahrén B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand. 2001 Feb;171(2):161-7.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B0283R/Acipimox-Standard-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B0283R/
CAS Number
51037-30-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-18114JF635 0.1 mL
Mouse Monoclonal IL-17B Antibody (B-B57) [Janelia Fluor 635]
Ask
View Details 